Sökning: "Hematological"
Visar resultat 1 - 5 av 150 avhandlingar innehållade ordet Hematological.
1. Coagulase-negative staphylococci in hematological malignancy
Sammanfattning : Bacterial infections are common in hematological malignancy. Coagulase-negative staphylococci (CoNS) are among the most prevalent causes of bacteremia in patients with hematological malignancies. LÄS MER
2. Platelet transfusions in hematological disorders
Sammanfattning : Platelets are important for clot formation and vascular integrity. Thrombocytopenic patients with hematological disorders are at risk of bleeding and platelet transfusions are important in supportive care and treatment of lite-threatening bleedings. LÄS MER
3. Bloodstream infections in patients with hematological malignancies
Sammanfattning : Patients with hematological malignancies have an increased risk of infectious complications. These complications can be caused by disease-specific factors or be treatment-related. Bloodstream infections increase the risk of morbidity, mortality, have a negative impact on quality of life, and may lead to reductions in treatment intensity. LÄS MER
4. Biosynthesis of leukotriene B4 in hematological malignancies
Sammanfattning : Leukotrienes (LT) are biologically active metabolites of the fatty acid arachidonic acid (AA). After liberation of AA by phospholipase A 2 (PLA 2), this fatty acid can be converted to leukotrienes, lipoxins, prostaglandins or thromboxane. The conversion of AA to LTA 4 is catalyzed by five-lipoxygenase (5-LO). LÄS MER
5. Viral infections in immunosuppressed patients with hematological malignancies
Sammanfattning : Acute or reactivated viral infections are common in patients who are immunosuppressed because of hematopoietic stem cell transplantation (HSCT) or chemotherapy due to hematological malignancies. The severity of the immunosuppression, the type of immune functions that are affected by various therapeutic interventions, as well as underlying hematological malignancy contributes to viral susceptibility and clinical outcome of the infection. LÄS MER